SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-077652
Filing Date
2023-07-03
Accepted
2023-07-03 16:56:12
Documents
1
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2320411-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2320411-3_4seq1.xml 4 5802
  Complete submission text file 0001104659-23-077652.txt   7290
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2125 1ST AVENUE #2902 SEATTLE WA 98121-2121
Business Address
Ferguson Kenneth M. (Reporting) CIK: 0001934344 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 231065764